Clinical Trial: Effect of Nalbuphine Combined with Remifentanil Multi-Mode Analgesia on Gastrointestinal Function after Traumatic Brain Injury (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Nalbuphine Combined with Remifentanil Multi-Mode Analgesia on Gastrointestinal Function after Traumatic Brain Injury'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129605

Registration Time: 2026/08/06

Type: Interventional study

Primary Sponsor: Shanghai Pudong New Area Gongli Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=305954

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Effect of Nalbuphine Combined with Remifentanil Multi-Mode Analgesia on Gastrointestinal Function after Traumatic Brain Injury (China)